(Q38961899)

8 September 2017

1 reference

title

Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy (English)

1 reference

8 September 2017

G Currie

1

1 reference

8 September 2017

C Delles

series ordinal

2

1 reference

8 September 2017

publication date

1 November 2016

1 reference

8 September 2017

published in

Current diabetes report

1 reference

8 September 2017

volume

16

1 reference

8 September 2017

issue

11

1 reference

8 September 2017

page(s)

104

1 reference

US Renal Data System 2012 Annual Data Report

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Overview: combating diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Diabetic kidney disease: a report from an ADA Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Measured GFR as a confirmatory test for estimated GFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Evaluation of the modification of diet in renal disease study equation in a large diverse population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Early renal function decline in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Diabetic kidney disease with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Higher levels of urinary albumin excretion within the normal range predict faster decline in glomerular filtration rate in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Biomarkers in diabetic nephropathy: Present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Surrogate endpoints in clinical trials of chronic kidney disease progression: moving from single to multiple risk marker response scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Overview: the maturing of proteomics in cardiovascular research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Proteomic strategies in the search of new biomarkers in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Optimizing a proteomics platform for urine biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Renal regulation of urine volume: potential implications for nocturia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Targeted proteomics of isolated glomeruli from the kidneys of diabetic rats: sorbin and SH3 domain containing 2 is a novel protein associated with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Proteome analysis of altered proteins in streptozotocin-induced diabetic rat kidney using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Classification, functions, and clinical relevance of extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Extracellular vesicles: masters of intercellular communication and potential clinical interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Extracellular vesicle isolation and characterization: toward clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary extracellular microvesicles: isolation methods and prospects for urinary proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary exosomes and diabetic nephropathy: a proteomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Analysis of urinary proteomic patterns for diabetic nephropathy by ProteinChip

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Protease profiling of different biofluids in type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary proteomics in diabetes and CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Urinary proteomics for early diagnosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

CKD273, a new proteomics classifier assessing CKD and its prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-016-0798-3

Underestimation of urinary albumin to creatinine ratio in morbidly obese subjects due to high urinary creatinine excretion

21 January 2018

1 reference

12 December 2020

Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder

1 reference

12 December 2020

Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome

1 reference

12 December 2020

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

12 December 2020

Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria

1 reference

12 December 2020

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

12 December 2020

Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002

1 reference

12 December 2020

Proteomic analysis of early urinary biomarkers of renal changes in type 2 diabetic patients

1 reference

12 December 2020

Changes in urine proteome accompanying diabetic nephropathy progression

1 reference

12 December 2020

10.1007/S11892-016-0798-3

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1033779200

0 references

1 reference